In addition, experiments focused on the therapeutic effect of MS-Hu6 in the treatment of osteoporosis and showed that MS-Hu6 can be distributed into the bone, providing the potential to use it to treat osteoporosis with high FSH levels (Gera et al., 2022). This evidence concerns the gene BRD2 and osteoporosis.